ResMed Current Ratio 2010-2025 | RMD

ResMed current ratio for the quarter ending March 31, 2025 was 3.41.

  • ResMed average current ratio for 2024 was 2.97, a 3.26% increase from 2023.
  • ResMed average current ratio for 2023 was 3.07, a 6.97% decline from 2022.
  • ResMed average current ratio for 2022 was 2.87, a 36.02% increase from 2021.

Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.

ResMed Current Ratio 2010-2025 | RMD

  • ResMed average current ratio for 2024 was 2.97, a 3.26% increase from 2023.
  • ResMed average current ratio for 2023 was 3.07, a 6.97% decline from 2022.
  • ResMed average current ratio for 2022 was 2.87, a 36.02% increase from 2021.

Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$209.7B
Boston Scientific (BSX)$154.8B
Stryker (SYK)$148.4B
EssilorLuxottica (ESLOY)$131.5B
Medtronic (MDT)$114.8B
Lonza Group Ag (LZAGY)$49.7B
Haleon (HLN)$43.1B
GE HealthCare Technologies (GEHC)$34.9B
Agilent Technologies (A)$33.1B
Terumo (TRUMY)$24.3B
Koninklijke Philips (PHG)$23.7B
Insulet (PODD)$19.9B
Zimmer Biomet Holdings (ZBH)$18.8B
Baxter (BAX)$14.3B
Smith & Nephew SNATS (SNN)$13.1B
Sunny Optical Technology (SNPTF)$10.4B
Demant (WILYY)$8.6B
Bio-Rad Laboratories (BIO)$6.8B
Lantheus Holdings (LNTH)$5.1B
Perrigo (PRGO)$3.7B
Prestige Consumer Healthcare (PBH)$3.7B
Haemonetics (HAE)$3.5B
Shandong Weigao Medical Polymer (SHWGF)$3.5B
Envista Holdings (NVST)$3.3B
ICU Medical (ICUI)$3.1B
LeMaitre Vascular (LMAT)$1.9B
QuidelOrtho (QDEL)$1.8B
AtriCure (ATRC)$1.5B
Acuren (TIC)$1.4B
AdaptHealth (AHCO)$1.2B